Stocks in play: Titan Medical Inc.
Has entered into a licensing agreement with Auris Health, Inc., a Johnson & Johnson MedTech company, in respect of certain intellectual property of Titan. Under the Agreement, Titan has granted Auris Health a non-exclusive license to a portion of Titan’s IP. Titan Medical Inc. shares T.TMD are trading down $0.03 at $0.16.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.